Exact FDA event identifier

Event 87029

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: December 17, 2020
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Imprimis NJOF, LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979

D-0177-2021

Recall number: D-0177-2021
Initiated: December 17, 2020
Classification: Class II
Status: Terminated
Recalling firm: Imprimis NJOF, LLC
Quantity: 6520 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.

Code information

Lot#: 20JUN010, Exp 5/12/21

Distribution pattern

U.S.A. Nationwide